1,148 filings
S-1
AIM
AIM ImmunoTech Inc
IPO registration
19 Apr 24
5:01pm
10-K
2023 FY
AIM
AIM ImmunoTech Inc
Annual report
29 Mar 24
9:18pm
4
Iii Peter W. Rodino
27 Mar 24
AIM ImmunoTech / Peter W Rodino III ownership change
1:54pm
4
Equels Thomas K.
27 Mar 24
AIM ImmunoTech / Thomas K Equels ownership change
1:52pm
4
Nancy Bryan
22 Mar 24
AIM ImmunoTech / NANCY BRYAN ownership change
1:30pm
4
AIM
AIM ImmunoTech Inc
18 Mar 24
AIM ImmunoTech / STEWART APPELROUTH ownership change
3:01pm
4
AIM
AIM ImmunoTech Inc
18 Mar 24
AIM ImmunoTech / Peter W Rodino III ownership change
3:01pm
4
AIM
AIM ImmunoTech Inc
18 Mar 24
AIM ImmunoTech / Thomas K Equels ownership change
3:01pm
D/A
AIM
AIM ImmunoTech Inc
21 Feb 24
$3.30 mm in debt, sold $3.30 mm, 1 investor
10:37am
D
AIM
AIM ImmunoTech Inc
20 Feb 24
Exempt offering of security
4:34pm
8-K
AIM
AIM ImmunoTech Inc
20 Feb 24
Entry into a Material Definitive Agreement
4:31pm
8-K
AIM
AIM ImmunoTech Inc
9 Feb 24
AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
3:47pm
8-K
AIM
AIM ImmunoTech Inc
25 Jan 24
Regulation FD Disclosure
5:00pm
8-K
AIM
AIM ImmunoTech Inc
10 Jan 24
Submission of Matters to a Vote of Security Holders
1:42pm
8-K
AIM
AIM ImmunoTech Inc
10 Jan 24
AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating
8:45am
SC 13D/A
Deutsch Todd
3 Jan 24
AIM ImmunoTech / Deutsch Todd ownership change
4:24pm
DFAN14A
Kellner Ted D
3 Jan 24
Additional proxy materials by non-management
4:24pm
DEFA14A
AIM
AIM ImmunoTech Inc
29 Dec 23
Additional proxy soliciting materials
8:15am
DEFA14A
AIM
AIM ImmunoTech Inc
28 Nov 23
Additional proxy soliciting materials
4:54pm
4
Equels Thomas K.
27 Nov 23
AIM ImmunoTech / Thomas K Equels ownership change
12:56pm